Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Giannoni

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Microorganisms|June 28, 2023
Eradication of Drug-Tolerant <i>Mycobacterium tuberculosis</i> 2022: Where We StandAlessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Annali Dell'Istituto Superiore Di Sanita|June 20, 2023
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020Federico Giannoni, Alessio Lanni, Angelo Iacobino, et al.
Tuberculosis (Edinburgh, Scotland)|June 8, 2024
Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overviewAndrea Sanchini, Alessio Lanni, Federico Giannoni, et al.
Mediterranean Journal of Hematology and Infectious Diseases|December 24, 2013
Targeting dormant bacilli to fight tuberculosisLanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, et al.
The Journal of Antibiotics|May 26, 2018
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditionsAngelo Iacobino, Federico Giannoni, Lanfranco Fattorini, et al.
International Journal of Mycobacteriology|August 5, 2017
Fighting tuberculosis by drugs targeting nonreplicating <i>Mycobacterium tuberculosis</i> bacilliAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Journal of Clinical Microbiology|September 15, 2017
Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide ResistanceAlessandro Mustazzolu, Angelo Iacobino, Federico Giannoni, et al.
Frontiers in Microbiology|August 18, 2025
Activity of combinations of bactericidal and bacteriostatic compounds in <i>Mycobacterium abscessus</i>-infected mice: an overviewAlessio Lanni, Elisabetta Iona, Lanfranco Fattorini, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosisGiovanni Piccaro, Donatella Pietraforte, Federico Giannoni, et al.
Microorganisms|January 30, 2021
Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent MannerAngelo Iacobino, Giovanni Piccaro, Manuela Pardini, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Microorganisms|June 28, 2023
Eradication of Drug-Tolerant <i>Mycobacterium tuberculosis</i> 2022: Where We StandAlessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Annali Dell'Istituto Superiore Di Sanita|June 20, 2023
Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016-2020Federico Giannoni, Alessio Lanni, Angelo Iacobino, et al.
Tuberculosis (Edinburgh, Scotland)|June 8, 2024
Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overviewAndrea Sanchini, Alessio Lanni, Federico Giannoni, et al.
Mediterranean Journal of Hematology and Infectious Diseases|December 24, 2013
Targeting dormant bacilli to fight tuberculosisLanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, et al.
The Journal of Antibiotics|May 26, 2018
Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditionsAngelo Iacobino, Federico Giannoni, Lanfranco Fattorini, et al.
International Journal of Mycobacteriology|August 5, 2017
Fighting tuberculosis by drugs targeting nonreplicating <i>Mycobacterium tuberculosis</i> bacilliAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Journal of Clinical Microbiology|September 15, 2017
Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide ResistanceAlessandro Mustazzolu, Angelo Iacobino, Federico Giannoni, et al.
Frontiers in Microbiology|August 18, 2025
Activity of combinations of bactericidal and bacteriostatic compounds in <i>Mycobacterium abscessus</i>-infected mice: an overviewAlessio Lanni, Elisabetta Iona, Lanfranco Fattorini, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosisGiovanni Piccaro, Donatella Pietraforte, Federico Giannoni, et al.
Microorganisms|January 30, 2021
Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent MannerAngelo Iacobino, Giovanni Piccaro, Manuela Pardini, et al.
Pageof 5